Literature DB >> 19403287

Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation.

Y Hu1, G E Davies.   

Abstract

It is known that a number of transcription factors are key regulators in the complex process of adipocyte differentiation including peroxisome proliferator activated receptor gamma (PPARgamma) and the CCAAT enhancer binding protein alpha (C/EBPalpha). Studies have demonstrated that in pre-adipocyte 3T3-L1 cells constitutive expression of the DNA binding proteins GATA-2 and GATA-3 results in protein/protein interactions with C/EBPalpha resulting in down regulation of PPARgamma and subsequent suppressed adipocyte differentiation with cells trapped at the pre-adipocyte stage. Thus it appears that GATA-2 and GATA-3 are of critical importance in regulating adipocyte differentiation through molecular interactions with PPARgamma and C/EBPalpha. Recent reports suggest that berberine, an isoquinoline derivative alkaloid isolated from many medicinal herbs prevents differentiation of 3T3-L1 cells via a down regulation of PPARgamma and C/EBPalpha expression. The aim of this study was to determine the effect of berberine on GATA-2 and 3 gene and protein expression levels during differentiation of 3T3-L1 cells. MTT (Methylthiazolyldiphenyl-tetrazolium bromide) was used to detect the cytotoxic effects of berberine on the viability of 3T3-L1 cells during proliferation and differentiation. Differentiation of 3T3-L1 cells was monitored by Oil Red O staining and RT-PCR of PPARgamma and C/EBPalpha and the expression of GATA-2 and 3 was determined by RT-PCR and Western Blot. Results show that following treatment with 8microM berberine the mRNA and protein expression levels of GATA-2 and 3 were elevated and accompanied by inhibited adipocyte differentiation. These results may lead to the use of berberine to target the induction of specific genes such as GATA-2 and GATA-3 which affect adipocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19403287     DOI: 10.1016/j.phymed.2009.03.002

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  11 in total

1.  Suppression of PPARγ through MKRN1-mediated ubiquitination and degradation prevents adipocyte differentiation.

Authors:  J-H Kim; K W Park; E-W Lee; W-S Jang; J Seo; S Shin; K-A Hwang; J Song
Journal:  Cell Death Differ       Date:  2013-12-13       Impact factor: 15.828

Review 2.  Fetal muscle development, mesenchymal multipotent cell differentiation, and associated signaling pathways.

Authors:  M Du; J X Zhao; X Yan; Y Huang; L V Nicodemus; W Yue; R J McCormick; M J Zhu
Journal:  J Anim Sci       Date:  2010-09-17       Impact factor: 3.159

3.  Effects of Rosmarinus officinalis extract on human primary omental preadipocytes and adipocytes.

Authors:  Bruno Stefanon; Elena Pomari; Monica Colitti
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-20

4.  Aspartame downregulates 3T3-L1 differentiation.

Authors:  Muthuraman Pandurangan; Jeongeun Park; Eunjung Kim
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-06-25       Impact factor: 2.416

5.  Berberine attenuates oxidative stress and hepatocytes apoptosis via protecting mitochondria in blunt snout bream Megalobrama amblycephala fed high-fat diets.

Authors:  Kang-Le Lu; Li-Na Wang; Ding-Dong Zhang; Wen-Bin Liu; Wei-Na Xu
Journal:  Fish Physiol Biochem       Date:  2016-08-06       Impact factor: 2.794

6.  Rohitukine inhibits in vitro adipogenesis arresting mitotic clonal expansion and improves dyslipidemia in vivo.

Authors:  Salil Varshney; Kripa Shankar; Muheeb Beg; Vishal M Balaramnavar; Sunil Kumar Mishra; Pankaj Jagdale; Shishir Srivastava; Yashpal S Chhonker; Vijai Lakshmi; Bhushan P Chaudhari; Rabi Shankar Bhatta; Anil Kumar Saxena; Anil Nilkanth Gaikwad
Journal:  J Lipid Res       Date:  2014-03-19       Impact factor: 5.922

7.  Berberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients.

Authors:  Jing Yang; Jinhua Yin; Hongfei Gao; Linxin Xu; Yan Wang; Lu Xu; Ming Li
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-08       Impact factor: 2.629

Review 8.  Barberry in the treatment of obesity and metabolic syndrome: possible mechanisms of action.

Authors:  Safieh Firouzi; Mahsa Malekahmadi; Majid Ghayour-Mobarhan; Gordon Ferns; Hamid Reza Rahimi
Journal:  Diabetes Metab Syndr Obes       Date:  2018-11-08       Impact factor: 3.168

9.  Metformin and berberine prevent olanzapine-induced weight gain in rats.

Authors:  Yueshan Hu; Alan J Young; Erik A Ehli; Dustin Nowotny; Paige S Davies; Elizabeth A Droke; Timothy J Soundy; Gareth E Davies
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

10.  Berberine inhibits adipocyte differentiation, proliferation and adiposity through down-regulating galectin-3.

Authors:  Can Wang; Yan Wang; Shu-Rong Ma; Zeng-Yan Zuo; Yan-Bin Wu; Wei-Jia Kong; Ai-Ping Wang; Jian-Dong Jiang
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.